C
Chongqing Pharscin Pharmaceutical Co Ltd
SZSE:002907
Chongqing Pharscin Pharmaceutical Co Ltd
SZSE:002907
Price:
14.16
CNY
-0.35%
Market Closed
Market Cap:
¥5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chongqing Pharscin Pharmaceutical Co Ltd
SZSE:002907
|
CN |
|
S
|
State Grid Yingda Co Ltd
SSE:600517
|
CN |
|
I
|
iSoftStone Information Technology Group Co Ltd
SZSE:301236
|
CN |
Income Statement
Earnings Waterfall
Chongqing Pharscin Pharmaceutical Co Ltd
Chongqing Pharscin Pharmaceutical Co Ltd
Income Statement
Chongqing Pharscin Pharmaceutical Co Ltd
Chongqing Pharscin Pharmaceutical Co Ltd
Currency: CNY
| Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
1
|
0
|
0
|
1
|
1
|
2
|
2
|
6
|
9
|
13
|
17
|
17
|
17
|
18
|
18
|
18
|
18
|
18
|
19
|
19
|
14
|
10
|
6
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
602
N/A
|
592
-2%
|
631
+7%
|
661
+5%
|
686
+4%
|
703
+3%
|
730
+4%
|
756
+3%
|
796
+5%
|
842
+6%
|
821
-3%
|
816
-1%
|
841
+3%
|
883
+5%
|
942
+7%
|
939
0%
|
903
-4%
|
846
-6%
|
819
-3%
|
778
-5%
|
762
-2%
|
785
+3%
|
770
-2%
|
778
+1%
|
739
-5%
|
692
-6%
|
732
+6%
|
749
+2%
|
791
+6%
|
775
-2%
|
785
+1%
|
799
+2%
|
787
-2%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(218)
|
(195)
|
(218)
|
(232)
|
(239)
|
(231)
|
(254)
|
(265)
|
(287)
|
(308)
|
(317)
|
(346)
|
(399)
|
(459)
|
(511)
|
(498)
|
(459)
|
(401)
|
(389)
|
(361)
|
(344)
|
(321)
|
(316)
|
(330)
|
(323)
|
(312)
|
(338)
|
(344)
|
(360)
|
(333)
|
(351)
|
(350)
|
(346)
|
|
| Gross Profit |
384
N/A
|
397
+3%
|
413
+4%
|
429
+4%
|
446
+4%
|
473
+6%
|
477
+1%
|
490
+3%
|
509
+4%
|
535
+5%
|
503
-6%
|
470
-7%
|
441
-6%
|
424
-4%
|
431
+2%
|
441
+2%
|
444
+1%
|
446
+0%
|
430
-4%
|
417
-3%
|
418
+0%
|
465
+11%
|
454
-2%
|
448
-1%
|
416
-7%
|
379
-9%
|
394
+4%
|
404
+3%
|
430
+6%
|
442
+3%
|
434
-2%
|
448
+3%
|
441
-2%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(255)
|
(267)
|
(276)
|
(285)
|
(298)
|
(318)
|
(317)
|
(296)
|
(318)
|
(333)
|
(305)
|
(300)
|
(289)
|
(285)
|
(281)
|
(309)
|
(310)
|
(339)
|
(330)
|
(314)
|
(329)
|
(350)
|
(343)
|
(356)
|
(342)
|
(338)
|
(343)
|
(355)
|
(357)
|
(360)
|
(351)
|
(366)
|
(368)
|
|
| Selling, General & Administrative |
(271)
|
(270)
|
(289)
|
(297)
|
(310)
|
(316)
|
(324)
|
(325)
|
(327)
|
(328)
|
(315)
|
(297)
|
(282)
|
(268)
|
(273)
|
(282)
|
(284)
|
(297)
|
(297)
|
(287)
|
(293)
|
(295)
|
(294)
|
(300)
|
(283)
|
(255)
|
(282)
|
(293)
|
(310)
|
(300)
|
(310)
|
(313)
|
(305)
|
|
| Research & Development |
0
|
(9)
|
0
|
0
|
(12)
|
(15)
|
(16)
|
(19)
|
(22)
|
(26)
|
(24)
|
(30)
|
(33)
|
(37)
|
(38)
|
(40)
|
(39)
|
(42)
|
(44)
|
(46)
|
(55)
|
(59)
|
(64)
|
(67)
|
(69)
|
(71)
|
(77)
|
(75)
|
(68)
|
(51)
|
(59)
|
(70)
|
(79)
|
|
| Depreciation & Amortization |
0
|
(11)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
16
|
23
|
13
|
12
|
23
|
25
|
22
|
47
|
32
|
34
|
35
|
27
|
25
|
30
|
30
|
13
|
12
|
12
|
11
|
19
|
19
|
17
|
15
|
11
|
11
|
14
|
15
|
14
|
21
|
21
|
18
|
17
|
15
|
|
| Operating Income |
129
N/A
|
130
+1%
|
137
+5%
|
144
+5%
|
148
+3%
|
154
+4%
|
160
+3%
|
194
+21%
|
191
-1%
|
201
+5%
|
199
-1%
|
171
-14%
|
152
-11%
|
139
-9%
|
149
+8%
|
132
-12%
|
134
+1%
|
106
-20%
|
100
-6%
|
103
+3%
|
89
-14%
|
114
+29%
|
111
-3%
|
92
-17%
|
74
-20%
|
42
-44%
|
51
+23%
|
50
-3%
|
74
+48%
|
82
+11%
|
83
+2%
|
82
-1%
|
72
-12%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
1
|
3
|
4
|
4
|
4
|
3
|
2
|
0
|
(3)
|
(5)
|
(7)
|
(5)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(8)
|
(6)
|
(1)
|
2
|
4
|
4
|
7
|
7
|
10
|
12
|
12
|
29
|
30
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
9
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
3
|
1
|
3
|
3
|
4
|
2
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(4)
|
(3)
|
(0)
|
(1)
|
(13)
|
(16)
|
|
| Pre-Tax Income |
132
N/A
|
132
N/A
|
143
+8%
|
152
+6%
|
156
+3%
|
161
+3%
|
163
+1%
|
196
+20%
|
191
-2%
|
198
+4%
|
194
-2%
|
164
-16%
|
147
-10%
|
137
-7%
|
147
+7%
|
129
-12%
|
131
+1%
|
103
-21%
|
95
-8%
|
98
+3%
|
80
-18%
|
108
+35%
|
110
+1%
|
94
-14%
|
78
-18%
|
43
-45%
|
55
+29%
|
53
-4%
|
80
+51%
|
93
+17%
|
95
+1%
|
98
+4%
|
94
-4%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
(21)
|
(20)
|
(23)
|
(23)
|
(25)
|
(24)
|
(24)
|
(28)
|
(28)
|
(28)
|
(28)
|
(23)
|
(20)
|
(18)
|
(19)
|
(17)
|
(17)
|
(12)
|
(10)
|
(11)
|
(5)
|
(10)
|
(11)
|
(7)
|
(7)
|
(10)
|
(12)
|
(14)
|
(17)
|
(17)
|
(18)
|
(17)
|
(24)
|
|
| Income from Continuing Operations |
112
|
112
|
120
|
128
|
131
|
137
|
139
|
167
|
163
|
170
|
166
|
141
|
127
|
119
|
128
|
113
|
114
|
92
|
85
|
87
|
75
|
98
|
99
|
88
|
70
|
33
|
43
|
39
|
63
|
77
|
77
|
82
|
70
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
|
| Net Income (Common) |
112
N/A
|
112
+0%
|
120
+7%
|
128
+7%
|
131
+2%
|
137
+5%
|
139
+1%
|
167
+20%
|
163
-2%
|
170
+4%
|
166
-2%
|
141
-16%
|
127
-10%
|
119
-6%
|
128
+7%
|
113
-12%
|
114
+1%
|
92
-19%
|
85
-8%
|
87
+3%
|
75
-14%
|
98
+31%
|
99
+1%
|
88
-11%
|
70
-20%
|
33
-54%
|
43
+31%
|
39
-10%
|
63
+62%
|
77
+23%
|
77
+0%
|
83
+9%
|
75
-11%
|
|
| EPS (Diluted) |
0.31
N/A
|
0.28
-10%
|
0.31
+11%
|
0.32
+3%
|
0.31
-3%
|
0.34
+10%
|
0.34
N/A
|
0.41
+21%
|
0.4
-2%
|
0.42
+5%
|
0.41
-2%
|
0.35
-15%
|
0.32
-9%
|
0.3
-6%
|
0.32
+7%
|
0.28
-12%
|
0.28
N/A
|
0.23
-18%
|
0.21
-9%
|
0.22
+5%
|
0.19
-14%
|
0.24
+26%
|
0.24
N/A
|
0.21
-13%
|
0.17
-19%
|
0.08
-53%
|
0.1
+25%
|
0.09
-10%
|
0.15
+67%
|
0.18
+20%
|
0.18
N/A
|
0.2
+11%
|
0.18
-10%
|
|
Switch to:
Switch to:
See Also
Discover More
